Mental DisorderCapExchangeNCT07620418
CapExchange: A Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery
A study testing CapExchange in people with Mental Disorder and Psychosocial Rehabilitation, run by EPSM de la Guadeloupe at 1 site in Guadeloupe.
Trial summary
CapExchange is a psychosocial rehabilitation programme based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Mental Disorder, Psychosocial Rehabilitation
- What is being tested?
- CapExchange
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteGuadeloupe
- Study dates
- 4 Jan 2027to 20 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18 years or over
- Stabilized mental disorder (no acute episode in the 3 months preceding inclusion)
- At least one identifiable practical skill exchangeable in a community context
- Free and informed consent to participation
Who cannot join
- Severe clinical instability at the time of inclusion
- Uncontrolled risk behaviour in social interactions
- Documented inability to engage in a reciprocity-based framework
- Opposition from legal guardian for service users under legal protection'
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Guadeloupe1 site
EPSM de la Guadeloupe
Saint-Claude, 97190
Ilyass El Mahfoudi, MD, +33608342789, ilyass.elmahfoudi@epsm-guadeloupe.fr
About this study
Official title: CapExchange: Study Protocol for a Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery
CapExchange is a psychosocial rehabilitation programme based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. This pilot feasibility study aims to assess the feasibility and acceptability of the programme within the Psychosocial Rehabilitation Service of the EPSM de la Guadeloupe, across three sites: the Unité Passerelle, the CATTG Doubs, and the UREPS outpatient unit. A sample of 10 to 15 adult service users with a stabilized mental disorder is targeted. The intervention comprises five weekly group sessions of 75 minutes. Primary measures include the Social Contribution Score (SCS) and the Warwick-Edinburgh Mental Well-being Scale (WEMWBS).
- Conditions
- Mental Disorder, Psychosocial Rehabilitation
- Being tested
- CapExchange
- Keywords
- recovery micro-social contribution pilot study service exchange Guadeloupe
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CapExchangeBehavioural
A structured group programme comprising five weekly sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution.
| Study group | Role | What they receive |
|---|---|---|
| CapExchange Programme | Experimental | Five weekly group sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment. Receives: Behavioral: CapExchange |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment rate
Proportion of eligible service users agreeing to participate in the programme
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2026
- Study start4 Jan 2027 (estimated)
- Primary completion15 Sep 2027 (estimated)
- Study completion20 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- EPSM de la Guadeloupe
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Ilyass El Mahfoudi, MD, Principal investigator, EPSM Guadeloupe
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07620418
- Sponsor's protocol ID
- CapExchange-2026-001
- Acronym
- CapExchange
- Status last verified
- May 2026
- First submitted
- 27 May 2026
- Last updated
- 29 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared given the pilot and feasibility nature of this study and the small sample size.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- CapExchange: Study Protocol for a Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery
- ClinicalTrials.gov ID
- NCT07620418
- Acronym / sponsor ID
- CapExchange / CapExchange-2026-001
- Conditions
- Mental Disorder, Psychosocial Rehabilitation
- Keywords
- recovery micro-social contribution pilot study service exchange Guadeloupe
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 15 participants (estimated)
- Lead sponsor
- EPSM de la GuadeloupeOther government
- Study start
- 4 Jan 2027 (estimated)
- Primary completion
- 15 Sep 2027 (estimated)
- Study completion
- 20 Dec 2027 (estimated)
- First posted
- 2 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
CapExchange is a psychosocial rehabilitation programme based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. This pilot feasibility study aims to assess the feasibility and acceptability of the programme within the Psychosocial Rehabilitation Service of the EPSM de la Guadeloupe, across three sites: the Unité Passerelle, the CATTG Doubs, and the UREPS outpatient unit. A sample of 10 to 15 adult service users with a stabilized mental disorder is targeted. The intervention comprises five weekly group sessions of 75 minutes. Primary measures include the Social Contribution Score (SCS) and the Warwick-Edinburgh Mental Well-being Scale (WEMWBS).
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CapExchange Programme | Experimental | Behavioral: CapExchangeFive weekly group sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults aged 18 years or over
- Stabilized mental disorder (no acute episode in the 3 months preceding inclusion)
- At least one identifiable practical skill exchangeable in a community context
- Free and informed consent to participation
Key exclusion criteria (4 listed)
- Severe clinical instability at the time of inclusion
- Uncontrolled risk behaviour in social interactions
- Documented inability to engage in a reciprocity-based framework
- Opposition from legal guardian for service users under legal protection'
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CapExchangeA structured group programme comprising five weekly sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. | Behavioural | CapExchange Programme |
Primary outcome
Recruitment rate
Time frame: 3 months
Proportion of eligible service users agreeing to participate in the programme
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jun 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared given the pilot and feasibility nature of this study and the small sample size.
Related trials for Mental Disorder
Not yet recruiting
FUS Neuromodulation for Binge Eating Disorder
Binge-Eating Disorder
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
Recruiting
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Alzheimer's Disease (AD), Frontotemporal Dementia (FTD)
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Enrolling by invitationPhase 2
Tau PET Outcomes With Anti-amyloid Immunotherapies
Cognitive Impairment, Mild, Dementia, Mild
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ilyass El Mahfoudi, MD principal investigator
EPSM Guadeloupe
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing CapExchange in people with Mental Disorder and Psychosocial Rehabilitation, run by EPSM de la Guadeloupe at 1 site in Guadeloupe.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Guadeloupe. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ilyass EL MAHFOUDI, MD (+33608342789, ilyass.elmahfoudi@epsm-guadeloupe.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment rate (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2026.